Skip to main content

Table 4 Comprehensive version of REST convergent validity with other measures

From: Construct validation of the Research Engagement Survey Tool (REST)

Other measures

Quality

Quantity

N

Spearman’s R

P value

N

Spearman’s R

P value

Medical Mistrust

322

0.11 (negligible)

0.05

325

0.12 (negligible)

0.03

Trust in Medical Researchers

322

0.18 (negligible)

< 0.001

324

0.21 (negligible)

< 0.001

Partnership Assessment in community-based Research (PAIR) Measure

322

0.34 (low)

< 0.001

325

0.44 (low)

< 0.001

Kagan Survey of community engagement

319

0.50 (moderate)

< 0.001

322

0.56 (moderate)

< 0.001

Community Engagement in Research Index (CERI)

320

0.19 (negligible)

0.001

323

0.25 (negligible)

< 0.001

Coalition Self-Assessment Survey (CSAS)—Trusta

323

0.40 (low)

< 0.001

328

0.42 (low)

< 0.001

Partnership self-assessment tool (PSAT)

PSAT—Synergy

325

0.61 (moderate)

< 0.001

328

0.62 (moderate)

< 0.001

PSAT—Satisfaction

324

0.61 (moderate)

< 0.001

327

0.65 (moderate)

< 0.001

PSAT—Leadership

323

0.69 (moderate)

< 0.001

326

0.69 (moderate)

< 0.001

PSAT—Efficiency

323

0.62 (moderate)

< 0.001

326

0.59 (moderate)

< 0.001

PSAT—Administration/Management

323

0.63 (moderate)

< 0.001

326

0.64 (moderate)

< 0.001

PSAT—Non-Financial Resources

322

0.47 (low)

< 0.001

325

0.52 (moderate)

< 0.001

PSAT—Financial and Other Capital Resources

320

0.34 (low)

< 0.001

323

0.32 (low)

< 0.001

PSAT—Decision Making

325

0.51 (moderate)

< 0.001

328

0.51 (moderate)

< 0.001

PSAT—Benefits

324

0.33 (low)

< 0.001

327

0.41 (low)

< 0.001

PSAT—Drawbacks

324

− 0.21 (negligible)

< 0.001

327

− 0.26 (negligible)

< 0.001

PSAT—Comparing Benefits and Drawbacks

323

0.39 (low)

< 0.001

326

0.42 (low)

< 0.001

Wilder Collaboration

325

0.54 (moderate)

< 0.001

328

0.54 (moderate)

< 0.001

  1. aCorrelation with EP8 (Build and maintain trust in the partnership) only